ATI Pharmacology

Questions 121

ATI RN

ATI RN Test Bank

ATI Pharmacology Questions

Question 1 of 5

A client with increased intracranial pressure is receiving Mannitol. Which finding should the nurse report to the provider?

Correct Answer: C

Rationale: Dyspnea is a concerning finding in a client receiving Mannitol as it can be a manifestation of heart failure, an adverse effect of the medication. The nurse should report this to the provider promptly to ensure appropriate evaluation and management.

Question 2 of 5

While caring for a client receiving epoetin alfa to treat anemia, which finding should the nurse monitor for?

Correct Answer: B

Rationale: The nurse should monitor the client for hypertension as a common adverse effect of epoetin alfa, which stimulates red blood cell production and can lead to increased blood pressure.

Question 3 of 5

A client is being discharged and will start long-term oral prednisone for chronic asthma treatment. The client should monitor for which of the following adverse effects of this medication?

Correct Answer: A

Rationale: Weight gain is an adverse effect of oral prednisone due to sodium and water retention, leading to fluid retention. Monitoring weight changes is important to detect this adverse effect early and take appropriate action.

Question 4 of 5

A client has a prescription for gentamicin for the treatment of an infection. Which finding indicates a potential adverse reaction to the medication?

Correct Answer: B

Rationale: The presence of red blood cells in the urine can indicate nephrotoxicity, which is a potential adverse effect of gentamicin. Gentamicin can cause damage to the kidneys, leading to the presence of red blood cells in the urine as a sign of renal impairment. Monitoring for this finding is crucial to detect and manage adverse reactions promptly.

Question 5 of 5

When providing teaching to a client starting therapy with trastuzumab, which finding should the nurse instruct the client to report?

Correct Answer: A

Rationale: The nurse should instruct the client to report dyspnea because it can indicate pulmonary toxicity, a serious adverse effect of trastuzumab. Monitoring and early reporting of respiratory symptoms like dyspnea are essential to prevent further complications and ensure timely intervention.

Similar Questions

Join Our Community Today!

Join Over 10,000+ nursing students using Nurselytic. Access Comprehensive study Guides curriculum for ATI-RN and 3000+ practice questions to help you pass your ATI-RN exam.

Call to Action Image